HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS • US4330001060
16.3 USD
+0.5 (+3.16%)
At close: Feb 13, 2026
16.1529 USD
-0.15 (-0.9%)
After Hours: 2/13/2026, 8:14:55 PM
Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 102 industry peers in the Health Care Providers & Services industry. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. HIMS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
- HIMS had positive earnings in the past year.
- HIMS had a positive operating cash flow in the past year.
- HIMS had negative earnings in 4 of the past 5 years.
- In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
- HIMS's Return On Assets of 5.99% is amongst the best of the industry. HIMS outperforms 82.35% of its industry peers.
- Looking at the Return On Equity, with a value of 23.03%, HIMS belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
- HIMS's Return On Invested Capital of 5.84% is fine compared to the rest of the industry. HIMS outperforms 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HIMS has a Profit Margin of 6.05%. This is amongst the best in the industry. HIMS outperforms 81.37% of its industry peers.
- HIMS has a Operating Margin of 5.96%. This is in the better half of the industry: HIMS outperforms 67.65% of its industry peers.
- With an excellent Gross Margin value of 75.01%, HIMS belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
- In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
- The number of shares outstanding for HIMS has been increased compared to 1 year ago.
- The number of shares outstanding for HIMS has been increased compared to 5 years ago.
- HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- HIMS has an Altman-Z score of 2.66. This is not the best score and indicates that HIMS is in the grey zone with still only limited risk for bankruptcy at the moment.
- HIMS has a Altman-Z score of 2.66. This is comparable to the rest of the industry: HIMS outperforms 58.82% of its industry peers.
- The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 8.13, HIMS is in line with its industry, outperforming 52.94% of the companies in the same industry.
- HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.67, HIMS is not doing good in the industry: 69.61% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 2.66 |
ROIC/WACC0.67
WACC8.68%
2.3 Liquidity
- HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.88, HIMS is in the better half of the industry, outperforming 77.45% of the companies in the same industry.
- HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- HIMS's Quick ratio of 1.64 is fine compared to the rest of the industry. HIMS outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 22.73% over the past year.
- HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
- The Revenue has grown by 78.02% in the past year. This is a very strong growth!
- The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
- HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.57% yearly.
- Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 22.80% on average per year.
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.8%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 30.19, the valuation of HIMS can be described as expensive.
- HIMS's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.19, HIMS is valued at the same level.
- A Price/Forward Earnings ratio of 28.04 indicates a quite expensive valuation of HIMS.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
- HIMS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.19 | ||
| Fwd PE | 28.04 |
4.2 Price Multiples
- HIMS's Enterprise Value to EBITDA ratio is in line with the industry average.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.06 | ||
| EV/EBITDA | 21.62 |
4.3 Compensation for Growth
- HIMS has a very decent profitability rating, which may justify a higher PE ratio.
- HIMS's earnings are expected to grow with 13.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.5
EPS Next 2Y3.76%
EPS Next 3Y13.74%
5. Dividend
5.1 Amount
- HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
16.3
+0.5 (+3.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners94.2%
Inst Owner Change-5.43%
Ins Owners5.93%
Ins Owner Change-1.41%
Market Cap3.71B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.27
Price Target43.45 (166.56%)
Short Float %35.26%
Short Ratio4.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-6.36%
PT rev (3m)-12.76%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-50.63%
EPS NY rev (1m)1.4%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.19 | ||
| Fwd PE | 28.04 | ||
| P/S | 1.68 | ||
| P/FCF | 31.06 | ||
| P/OCF | 11.41 | ||
| P/B | 6.39 | ||
| P/tB | 29.26 | ||
| EV/EBITDA | 21.62 |
EPS(TTM)0.54
EY3.31%
EPS(NY)0.58
Fwd EY3.57%
FCF(TTM)0.52
FCFY3.22%
OCF(TTM)1.43
OCFY8.76%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)0.5
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 2.66 |
F-Score3
WACC8.68%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.8%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.58%
EBIT Next 3Y89.54%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 3 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.